Clinical Trials
Optimal Surgical Margin in Hepatocellular Carcinoma After HAIC Conversion Therapy
Deng et alBMC Medicine

A target trial emulation study investigated the optimal surgical margin width for patients with hepatocellular carcinoma (HCC) undergoing curative R0 resection after hepatic arterial infusion chemotherapy (HAIC)–based conversion therapy. While conventional management in chemotherapy-naïve HCC often advocates for a 1 cm resection margin, the locoregional tumor sterilization induced by HAIC challenges whether wide parenchymal margins remain oncologically necessary.
Using observational data balanced via stabilized inverse probability of treatment weighting to adjust for baseline confounders, the authors compared patient outcomes between narrow margins and wide margins (greater vs less than 1 cm). Analysis of the weighted cohort demonstrated that narrow resection margins yielded overall survival (HR, 0.96; 95% CI: 0.70–1.31; P = 0.784) and recurrence-free survival (HR, 0.83; 95% CI: 0.65–1.06; P = 0.136) rates statistically indistinguishable from those obtained with wide margins.
This prognostic equivalence was maintained across multiple sensitivity analyses testing alternative margin thresholds, including ≥ 0.5 cm versus < 0.5 cm, > 0 cm versus 0 cm, and 0.1 cm versus 0 cm. However, exploratory subgroup evaluations indicated that extended clearances might provide a survival advantage in high-risk tumor phenotypes. The authors concluded that a 1 cm margin was not associated with improved survival outcomes, suggesting that achieving a microscopically negative R0 margin may serve as an adequate surgical endpoint, with wider resections potentially reserved for biologically aggressive disease.
Key Takeaways
- In patients undergoing curative R0 resection following HAIC-based conversion therapy, a narrow surgical margin achieved overall survival (HR, 0.96; 95% CI: 0.70–1.31; P = 0.784) and recurrence-free survival (HR, 0.83; 95% CI: 0.65–1.06; P = 0.136) comparable to a wide margin of 1 cm or greater.
- Prognostic equivalence between resection widths persisted across sensitivity analyses evaluating thresholds of ≥ 0.5 cm vs < 0.5 cm, > 0 cm vs 0 cm, and 0.1 cm vs 0 cm, indicating that routine parenchymal clearance beyond a negative R0 margin does not confer an oncologic benefit.
- Exploratory subgroup interactions suggested that extended resection margins might offer a survival advantage specifically in patients exhibiting biologically aggressive, high-risk phenotypes.
Read the original sourceBMC Medicine
